Topics

TB Alliance's pretomanid gains FDA approval as part of three-drug regimen for highly drug-resistant TB https://www.firstwordpharma.com/node/1659527 

05:51 EDT 15 Aug 2019 | FirstWord Pharma

TB Alliance's pretomanid gains FDA approval as part of three-drug regimen for highly drug-resistant TB https://www.firstwordpharma.com/node/1659527 

Original Article: TB Alliance's pretomanid gains FDA approval as part of three-drug regimen for highly drug-resistant TB https://www.firstwordpharma.com/node/1659527 

NEXT ARTICLE

More From BioPortfolio on "TB Alliance's pretomanid gains FDA approval as part of three-drug regimen for highly drug-resistant TB https://www.firstwordpharma.com/node/1659527 "

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...